Best Penny Stocks Under 25 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.25 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.25. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. NuCana NASDAQ:NCNA$0.08 -0.01 (-7.46%) As of 12:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. More about NuCanaMarket Capitalization$500 thousandP/E Ratio-0.01Consensus RatingModerate BuyConsensus Price Target$25.00 (+30,425.0% Upside)Volume13.99 million sharesAverage Volume35.81 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. WW International NASDAQ:WW$0.25 -0.03 (-10.51%) As of 05/15/2025WW International, Inc provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. More about WW InternationalMarket Capitalization$20.04 millionP/E Ratio-0.04Consensus RatingHoldConsensus Price Target$2.25 (+801.4% Upside)Volume10.45 million sharesAverage Volume11.36 million shares3. Nikola NASDAQ:NKLA$0.18 -0.07 (-28.74%) Closing price 02/25/2025Extended Trading$0.18 0.00 (0.00%) As of 02/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$11.14 millionP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$6.00 (+3,178.7% Upside)Volume36.66 million sharesAverage Volume10.12 million shares4. Sunnova Energy International NYSE:NOVA$0.16 -0.06 (-28.25%) Closing price 06/9/2025Extended Trading$0.16 0.00 (0.00%) As of 06/9/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sunnova Energy International Inc engages in the provision of energy as a service in the United States. The company offers electricity, as well as offers operations and maintenance, monitoring, repairs and replacements, equipment upgrades, on-site power optimization, and solar energy system and energy storage system diagnostics services. More about Sunnova Energy InternationalMarket Capitalization$19.86 millionP/E Ratio-0.05Consensus RatingHoldConsensus Price Target$4.36 (+2,657.7% Upside)Volume4.22 million sharesAverage Volume11.17 million shares5. Abpro NASDAQ:ABP$0.22 +0.00 (+0.28%) As of 11:42 AM EasternAbpro Holdings Inc is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. More about AbproMarket Capitalization$13.23 millionConsensus RatingBuyConsensus Price Target$4.00 (+1,738.2% Upside)Volume1.25 million sharesAverage Volume5.71 million sharesToday's Range$0.21▼$0.226. Affimed NASDAQ:AFMD$0.18 -0.10 (-34.95%) As of 05/19/2025Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany. More about AffimedMarket Capitalization$2.92 millionConsensus RatingHoldConsensus Price Target$3.62 (+1,895.9% Upside)Volume22.99 million sharesAverage Volume4.48 million sharesToday's Range$0.17▼$0.247. Lazydays NASDAQ:GORV$0.23 -0.01 (-3.77%) As of 11:58 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Lazydays Holdings, Inc operates recreational vehicle (RV) dealerships under the Lazydays name in the United States. The company offers RV sales, RV-repair and services, financing and insurance products, third-party protection plans, and after-market parts and accessories. More about LazydaysMarket Capitalization$25.81 millionP/E Ratio-0.03Consensus RatingHoldConsensus Price Target$2.00 (+781.1% Upside)Volume64,390 sharesAverage Volume2.28 million shares8. Omega Therapeutics NASDAQ:OMGA$0.12 -0.03 (-21.83%) Closing price 02/24/2025Extended Trading$0.12 0.00 (0.00%) As of 02/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega TherapeuticsMarket Capitalization$6.92 millionP/E Ratio-0.09Consensus RatingModerate BuyConsensus Price Target$8.50 (+6,700.0% Upside)Volume4.81 million sharesAverage Volume3.45 million shares9. Zapp Electric Vehicles Group NASDAQ:ZAPP$0.15 -0.13 (-46.31%) As of 05/19/2025Zapp Electric Vehicles Group Ltd. engages in the provision of designs, manufactures and sells electric vehicles. It operates through the following geographical segments: Cayman Islands, Europe, and Thailand. More about Zapp Electric Vehicles GroupMarket Capitalization$1.23 millionConsensus RatingBuyConsensus Price Target$3.00 (+1,838.0% Upside)Volume13.38 million sharesAverage Volume2.59 million sharesToday's Range$0.14▼$0.2210. Adaptimmune Therapeutics NASDAQ:ADAP$0.23 -0.02 (-8.30%) As of 11:58 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. More about Adaptimmune TherapeuticsMarket Capitalization$61.49 millionP/E Ratio-0.86Consensus RatingHoldConsensus Price Target$1.35 (+482.6% Upside)Volume807,900 sharesAverage Volume1.68 million shares11. Dragonfly Energy NASDAQ:DFLI$0.18 -0.01 (-3.35%) As of 11:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Dragonfly Energy Holdings Corp. engages in the manufacturing and sale of deep cycle lithium-ion batteries for recreational vehicles, marine vessels, solar and off-grid residence industries, and industrial and energy storage markets. More about Dragonfly EnergyMarket Capitalization$1.69 millionP/E Ratio-0.03Consensus RatingModerate BuyConsensus Price Target$1.50 (+738.0% Upside)Volume3.42 million sharesAverage Volume1.81 million shares12. Beyond Air NASDAQ:XAIR$0.17 -0.01 (-3.21%) As of 11:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. More about Beyond AirMarket Capitalization$14.60 millionP/E Ratio-0.21Consensus RatingBuyConsensus Price Target$1.50 (+787.6% Upside)Volume848,248 sharesAverage Volume1.57 million shares13. Wag! Group NASDAQ:PET$0.11 0.00 (-0.09%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Wag! Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. More about Wag! GroupMarket Capitalization$5.38 millionP/E Ratio-0.27Consensus RatingModerate BuyConsensus Price Target$4.17 (+3,794.1% Upside)Volume1.04 million sharesAverage Volume2.24 million shares14. Calidi Biotherapeutics NYSE:CLDI$0.23 0.00 (-1.57%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Calidi Biotherapeutics, Inc, a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate and deliver oncolytic viruses to cancer patients in the United States. More about Calidi BiotherapeuticsMarket Capitalization$7.19 millionConsensus RatingBuyConsensus Price Target$10.00 (+4,324.8% Upside)Volume517,114 sharesAverage Volume995,326 sharesToday's Range$0.20▼$0.2415. Syros Pharmaceuticals NASDAQ:SYRS$0.03 0.00 (-1.49%) As of 11:21 AM EasternSyros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. More about Syros PharmaceuticalsMarket Capitalization$708 thousandP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$3.33 (+12,526.3% Upside)Volume6,411 sharesAverage Volume8.06 million shares16. Bio-Path NASDAQ:BPTH$0.19 +0.01 (+6.29%) As of 10:13 AM EasternBio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. More about Bio-PathMarket Capitalization$1.55 millionConsensus RatingBuyConsensus Price Target$20.00 (+10,652.7% Upside)Volume23,366 sharesAverage Volume989,726 sharesToday's Range$0.17▼$0.2017. LeddarTech NASDAQ:LDTC$0.07 -0.12 (-61.84%) Closing price 06/18/2025Extended Trading$0.07 0.00 (0.00%) As of 06/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LeddarTech Holdings Inc provides AI-based fusion and perception software solutions for advanced driver assistance solutions and autonomous driving applications in Canada. More about LeddarTechMarket Capitalization$2.09 millionP/E Ratio-0.02Consensus RatingModerate BuyConsensus Price Target$3.00 (+4,037.9% Upside)Volume20.95 million sharesAverage Volume2.41 million shares18. Stardust Power NASDAQ:SDST$0.20 -0.01 (-2.96%) As of 11:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$11.85 millionP/E Ratio-0.27Consensus RatingBuyConsensus Price Target$5.11 (+2,495.2% Upside)Volume2.06 million sharesAverage Volume695,158 shares19. American Lithium NASDAQ:AMLI$0.24 -0.01 (-3.80%) As of 06/25/2025American Lithium Corp., an exploration and development stage company, engages in the acquisition, exploration, and development of resource properties in the United States. More about American LithiumMarket Capitalization$52.39 millionP/E Ratio-2.40Consensus RatingBuyConsensus Price Target$3.25 (+1,251.9% Upside)Volume39,042 sharesAverage Volume551,645 shares20. Aspira Women's Health NASDAQ:AWH$0.08 -0.01 (-12.49%) As of 04/16/2025Aspira Women's Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. More about Aspira Women's HealthMarket Capitalization$2.44 millionP/E Ratio-0.07Consensus RatingBuyConsensus Price Target$5.50 (+6,607.3% Upside)Volume4.31 million sharesAverage Volume1.49 million shares21. Cutera NASDAQ:CUTR$0.04 -0.07 (-63.86%) Closing price 03/12/2025Extended Trading$0.04 0.00 (0.00%) As of 03/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. More about CuteraMarket Capitalization$787 thousandP/E Ratio-0.01Consensus RatingModerate BuyConsensus Price Target$3.00 (+7,592.3% Upside)Volume27.70 million sharesAverage Volume2.72 million shares22. Palatin Technologies NYSEAMERICAN:PTN$0.10 -0.07 (-43.76%) Closing price 05/7/2025Extended Trading$0.10 0.00 (0.00%) As of 05/7/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. More about Palatin TechnologiesMarket Capitalization$2.49 millionP/E Ratio-0.06Consensus RatingBuyConsensus Price Target$7.00 (+7,222.2% Upside)Volume14.57 million sharesAverage Volume1.08 million shares23. T2 Biosystems NASDAQ:TTOO$0.15 +0.01 (+8.57%) As of 11:34 AM EasternT2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. More about T2 BiosystemsMarket Capitalization$3.20 millionConsensus RatingHoldConsensus Price Target$5.00 (+3,189.5% Upside)Volume19,101 sharesAverage Volume580,355 sharesToday's Range$0.13▼$0.1524. Ayr Wellness OTCMKTS:AYRWF$0.19 -0.02 (-10.29%) As of 11:05 AM EasternAyr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. More about Ayr WellnessMarket Capitalization$21.78 millionP/E Ratio-0.06Consensus RatingModerate BuyConsensus Price Target$3.00 (+1,500.0% Upside)Volume1,158 sharesAverage Volume294,301 shares25. Spruce Biosciences NASDAQ:SPRB$0.07 0.00 (-5.43%) As of 11:05 AM EasternSpruce Biosciences, Inc, a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. More about Spruce BiosciencesMarket Capitalization$2.80 millionP/E Ratio-0.07Consensus RatingHoldConsensus Price Target$1.75 (+2,543.5% Upside)Volume65,379 sharesAverage Volume699,114 shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside AeroVironment Will Hit New Highs This Year: Bull Flag Confirmed FedEx Stock Is at Its Bottom—And It May Be Time to Buy Deere & Co.: A Quiet Industrial Leader Gaining Steam Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides Palantir Stock Hits ATH, But Can the Rally Hold Without Volume? Costco at a Crossroads: Is the Next Move Higher or Lower? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
